At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Promoting Smoking Cessation in Lung Cancer Screening Through Proactive Treatment
In Brief
A clinical study evaluating Unsigned note to provider about cessation medication prescription and Proactive Telephone Counseling from VA Quitline for Smoking Reduction and 5 related conditions. Completed, enrolled 944 participants across 3 sites.
Detailed Summary
This pragmatic trial will evaluate the value of routinely providing proactive smoking cessation support to current smokers as a part of participating in lung cancer screening within Veterans Health Administration.
Study Details
Timeline
Interventions
For patients of providers assigned to the proactive study group, a local coordinator will review the patient's cessation medication history. If the patient is not currently being provided cessation support medication, the coordinator will enter a note for the provider about the recommended medication indicated by VA formulary guidelines.
Patients of providers assigned to the proactive study group will be contacted by specially trained counselors at the VA Quitline. Counselors will attempt to provide two sessions of proactive telephone support.